Fate of Glenmark's Crofelemer uncertain on legal dispute

  • 2:14
  • Published On: July 28, 2011
Cinema View
Embed

Pharma major Glenmark's drug Crofelemer promises huge opportunities but its marketing partners Napo Pharma and Salix Pharma are embroiled in a legal dispute. This is likely to affect its launch in the market.

Related Videos

"If Government Action Was Enough, Why Is WHO Still Flagging Indian-Made Drugs?" Asks Expert
August 13, 2023 7:12
WHO Alert For Indian Drug, 5th In 10 Months: 'Jan Vishwas', The Law We Need?
August 13, 2023 24:21
"Chemicals Within Safe Limits": Indian Firm After WHO Flags Syrup In Iraq
August 08, 2023 1:55
Sun Pharma Q4 Profit In Line With Estimates
May 26, 2023 0:35
"No Contamination Found": Tamil Nadu Official As US Flags Indian Eye Drop
April 04, 2023 2:17
Drug Major Sun Pharma Hit By Ransomware Attack
March 27, 2023 1:53
2 Dead, 2 Injured In Explosion At Gujarat Pharma Company
February 28, 2023 1:32
Late Night Inspection At Chennai Firm Linked To Vision Loss, Death In US
February 04, 2023 2:23
Top Headlines Of The Day: February 4, 2023
February 04, 2023 1:52
The Biggest Stories Of February 3, 2023
February 03, 2023 20:49
Indian Company Recalls Eyedrops Linked To Infection Death In US
February 03, 2023 3:08
Finance Minister Announces New Programme To Promote Research In Pharma
February 01, 2023 0:43
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination